Search
Inosine
go.drugbank.com/drugs/DB04335ApprovedA purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in ...
Vapendavir
go.drugbank.com/drugs/DB05181InvestigationalBTA798 is an antiviral for the treatment of HRV, the common cold virus, known to cause significant clinical complications in sufferers of Asthma and Chronic Obstructive Pulmonary Disease.
Sargramostim
go.drugbank.com/drugs/DB00020ApprovedInvestigationalSargramostim is a human recombinant granulocyte macrophage colony-stimulating factor (GM-CSF) expressed in yeast. It is a glycoprotein that is 127 residues. Substitution of Leu23 leads to a difference from native protein.
Foretinib
go.drugbank.com/drugs/DB12307InvestigationalForetinib has been used in trials studying the treatment of Cancer, Breast Cancer, Carcinoma, Renal Cell, Recurrent Breast Cancer, and Neoplasms, Head and Neck, among others. Foretinib is an orally available small molecule compound desig...
Heparan-N-sulfatase (human, recombinant)
go.drugbank.com/drugs/DB18483InvestigationalRecombinant human heparan-N-sulfatase (rhHNS) is under investigation for the treatment mucopolysaccharidosis type IIIA.
Fluocortin
go.drugbank.com/drugs/DB13223ExperimentalFluocortin has been studied as a corticosteroid for treatment of dermatitis and eczema Spain [A174817].
Ulinastatin
go.drugbank.com/drugs/DB12038InvestigationalUlinastatin has been investigated for the prevention of Cardiovascular Disease and Adverse Reaction to Drug.
Atopaxar
go.drugbank.com/drugs/DB12046InvestigationalAtopaxar has been investigated for the treatment of Coronary Artery Disease and Acute Coronary Syndrome.
AZD-7762
go.drugbank.com/drugs/DB12242InvestigationalAZD7762 has been investigated for the treatment of Cancer, Solid Tumors, and Advanced Solid Malignancies.
Utomilumab
go.drugbank.com/drugs/DB15113InvestigationalUtomilumab is under investigation in clinical trial NCT03318900 (T Cell Immunotherapy for Advanced Ovarian Cancer).